NTRK1 and neoplasm: The latter were previously generated from transgenic MMTV-PyMT mice in which mammary epithelium directed expression of the polyoma middle T antigen (PyMT) drives breast carcinogenesis by activating receptor tyrosine kinase pathways involved in human breast carcinogenesis, including the PI3K axis 36,37.